INDIANAPOLIS, Jan. 14, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin by ...
Eli Lilly and Company announced that the US Food and Drug Administration (FDA) approved the company's supplemental New Drug Application (sNDA) with the following updates to the Humalog label: ...
Insulin lispro protamine suspension 75% (rDNA origin), insulin lispro 25% (rDNA origin) 100 Units/mL; SC inj; contains zinc, m-cresol. The primary activity of insulin is the regulation of glucose ...
(Reuters) - Eli Lilly and Co said on Tuesday it plans to sell two versions of insulin products at half their current U.S. list prices, eight months after it started selling a half-priced version of ...
The list price is $137.35 per vial. This story is from Kaiser Health News When Erin Gilmer filled her insulin prescription at a Denver-area Walgreens in January, she paid $8.50. U.S. taxpayers paid ...
Lower-priced versions of Humalog Mix 75/25 KwikPen (insulin lispro protamine and insulin lispro injectable suspension 100Units/mL) and Humalog Junior KwikPen (insulin lispro injection 100Units/mL) ...
A half-price version of Eli Lilly’s popular Humalog insulin is now available, following the company’s promise in March to offer diabetics a more affordable option amid fierce criticism of soaring ...
When Erin Gilmer filled her insulin prescription at a Denver-area Walgreens in January, she paid $8.50. U.S. taxpayers paid another $280.51. "It eats at me to know that taxpayer money is being wasted, ...
Drugmaker Eli Lilly warned this week that two of its formulations of insulin would be temporarily out of stock through the beginning of April, citing a “brief delay in manufacturing.” The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback